ras oncogene p21 as a tumor marker in the cytodiagnosis of gastric and colonic carcinomas.
This study was undertaken to determine whether the expression of ras oncogene product p21 can be used as a tumor cell marker of gastric and colonic carcinoma in brush smears. To detect p21 an immunocytochemical assay with RAP-5 monoclonal antibody was used. Benign epithelial gastric cells obtained from normal gastric mucosa or benign gastric lesions reacted negatively in 12 out of 13 cases. Similarly, benign epithelial colonic cells from normal colon or benign colonic lesions were negative for p21 in nine out of ten cases. Weakly positive reaction, confined to a few cell clusters only, was observed in one smear of a benign gastric ulcer and one smear of chronic ulcerative colitis. All 20 smears from colonic carcinoma and all 20 smears of gastric carcinoma contained cells that stained positively for p21, and the degree of tumor differentiation had no impact on the staining pattern. The results recorded in this study show that the immunocytochemical assay for the ras oncogene product may prove to represent a new tool for the cytodiagnosis of gastric and colonic carcinomas.
Czerniak
B
B
Department of Pathology, Montefiore Medical Center, Bronx, NY 10467.
Herz
F
F
Koss
L G
LG
Schlom
J
J
D000911:Antibodies, Monoclonal; D003092:Colitis / Q000175:diagnosis; D003110:Colonic Neoplasms / Q000032:analysis / Q000175:diagnosis*; D003113:Colonoscopy; D003937:Diagnosis, Differential; D004848:Epithelium / Q000032:analysis; D005756:Gastritis / Q000175:diagnosis; D005773:Gastroscopy; D006801:Humans; D009363:Neoplasm Proteins / Q000032:analysis*; D011518:Proto-Oncogene Proteins / Q000032:analysis*; D016283:Proto-Oncogene Proteins p21(ras); D013274:Stomach Neoplasms / Q000032:analysis / Q000175:diagnosis*; D013276:Stomach Ulcer / Q000175:diagnosis
D000911:Antibodies, Monoclonal; D009363:Neoplasm Proteins; D011518:Proto-Oncogene Proteins; C501009:HRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras)